A Prospective Study of Risperdal® (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children - Related Studies

A Prospective Study of Risperdal® (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

This study has been completed.

Study NCT00254930. Last updated on November 20, 2008. Information provided by Janssen-Cilag Ltd.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Child Behavior Disorders
		Learning Disorders

2	Additional conditions recognized in this trial
		Disease
		Mental Disorders

3	More general conditions related to this trial
		Communication Disorders
		Mental Disorders Diagnosed in Childhood
		Nervous System Diseases
		Neurobehavioral Manifestations
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms

4	Interventions listed in this trial
		risperidone

5	More general drug interventions related to this trial
		Antipsychotic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Dopamine Agents
		Dopamine Antagonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Antagonists
		Therapeutic Uses
		Tranquilizing Agents

6	Sponsors listed in this trial
		Janssen-Cilag Ltd.